Sunscreen Meetings

The following is a list of meetings that have occurred between FDA and stakeholders on the topic of sunscreens.

April 18, 2024: Listening session with American Academy of Dermatology Association (AADA)

• Meeting Materials
• Meeting Minutes

December 1, 2023: Listening session with Public Access to Sunscreen Coalition (PASS)

• Meeting Minutes
• PASS Follow-up Letter

August 18, 2023: Monograph File (MGF) 400074 type Z meeting with Personal Care Products Council (PCPC)

• Meeting Request
• Meeting Granted
• Meeting Package
• FDA Preliminary Comments
• PCPC Response to FDA Preliminary Comments
• Meeting Minutes
• PCPC Withdrawal from OTC Sunscreen Industry Working Group

March 24, 2023: MGF 400062 type Z meeting with PCPC

• Meeting Request
• Meeting Granted
• Meeting Package
• FDA Preliminary Comments
• PCPC Response to FDA Preliminary Comments
• Meeting Minutes

December 6, 2022: MGF 400060 type Z meeting request from PCPC

• Meeting Request
• Unacceptable for Formal Meeting Request Letter

March 22, 2022: MGF 400005 meeting request from EMD Performance Materials Corp. and the Avon Company

• Meeting Request
• Meeting Request Acknowledgement
• Meeting Denied

April 23, 2021: Listening session with Environmental Working Group (EWG)

• Meeting Minutes

April 20, 2021: Listening session with PASS

• Meeting Minutes

March 17, 2021: MGF 400000 meeting request from PCPC¹

• Meeting Request
• Meeting Granted
• Meeting Materials
• OTC Industry Working Group Contact Change
• Unacceptable for Formal Meeting Request Letter
• Meeting Cancellation

November 13, 2019: Public meeting with PCPC

• Meeting Request
• Meeting Granted
• Meeting Package
• FDA Preliminary Comments
• Announcement Granting PCPC Request for Meeting Postponement
• Second Announcement Granting PCPC Request for Meeting Postponement

June 7, 2019: Non-public meeting with DSM Nutritional Products LLC (DSM)

• Meeting Request
• Meeting Granted
• Meeting Minutes 

October 12, 2017: Non-public meeting with BASF Corp ("BASF")

• Meeting Request
• Meeting Granted
• Meeting Package
• Meeting Minutes 

September 7, 2016: Meeting with PCPC.

• Meeting Request
• Meeting Minutes

May 11, 2015: Meeting with L’Oréal USA Products Inc.

• Meeting Granted
• Meeting Minutes
• L'Oreal Response to FDA Meeting Minutes
• FDA Advice Letter

March 20, 2015: Meeting with BASF SE

• Meeting Granted
• Meeting Minutes

March 19, 2015: Meeting with BASF SE

• Meeting Granted (also available at FDA-2005-N-0453-0041)
• Meeting Minutes (also available at FDA-2005-N-0453-0042)
• FDA Advice Letter (also available at FDA-2005-N-0453-0046)

March 18, 2015: Meeting with L’Oréal USA Products Inc.

• Meeting Granted
• Meeting Cancellation

February 4, 2015: Meeting with Consumer Healthcare Products Association (CHPA), EWG, PCPC, and PASS

• Meeting Announcement
• Summary of Meeting
• Meeting Materials

---

¹The Coronavirus Aid, Relief and Economic Security (CARES) Act was enacted on March 27, 2020, and included important provisions reforming the way that OTC monograph drugs are regulated in the US. Among other things, the CARES Act replaced the previous rulemaking process for establishing, revising, and amending OTC monographs with an administrative order process. See OTC Monograph Resources for more information about OTC monograph reform and drug regulation under the CARES Act.

Back to Sunscreen Innovation Act page